AlphaGrep UK’s Wave Life Sciences WVE Stock Holding History

AlphaGrep UK’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-13,379	Closed	-$77.7K	–	967
2026 Q2	$77.7K	Sell	13,379 -8,235	-38%	-$54.6K	0.02%	713
2026 Q1	$157K	Buy	+21,614	New	+$282K	0.05%	740

Other funds holding WVE

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

GSK plc London $497M AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

M28 Capital Management Stamford, Connecticut $36M AUM 11.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

AlphaGrep UK's WVE Position: Q3 2026 in Review

AlphaGrep UK sold out of Wave Life Sciences (WVE) in Q3 2026, closing a stake of 13,379 shares — an estimated $77.7K sold.

AlphaGrep UK first reported a position in WVE in Q1 2026 and held it in 2 quarters. The position peaked at $157K in Q1 2026. 149 funds tracked by Wall St. Rank hold WVE as of Q3 2026.

AlphaGrep UK reported no remaining Wave Life Sciences position as of Q3 2026 after selling out during the quarter.
AlphaGrep UK sold 13,379 Wave Life Sciences shares in Q3 2026, an estimated $77.7K.
AlphaGrep UK first reported a position in Wave Life Sciences in Q1 2026 and held it in 2 quarters.
AlphaGrep UK's Wave Life Sciences position peaked at $157K in Q1 2026.
149 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.